Glenmark Pharmaceuticals cuts price of antiviral drug Favipiravir

14 Jul 2020 Evaluate

Glenmark Pharmaceuticals has cut price of antiviral drug Favipiravir --sold under the brand name FabiFlu for the treatment of patients with mild to moderate COVID-19 by 27 percent to Rs 75 per tablet. The company had launched the drug in June at a price of Rs 103 per tablet.

The price reduction has been made possible through benefits gained from higher yields and better scale, as both the active pharmaceutical ingredient (API) and formulations are made at Glenmark's facilities in India, the benefits of which are being passed on to patients in the country.

Glenmark Pharmaceuticals is a global researchled pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.

Glenmark Pharma Share Price

1986.70 -13.90 (-0.69%)
19-Jan-2026 10:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1663.35
Dr. Reddys Lab 1169.60
Cipla 1375.60
Zydus Lifesciences 864.70
Lupin 2165.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×